Ludwig Hantson, CEO at ALEXION PHARMACEUTICALS INC (ALXN), sold 26,490 shares at $116.31 ($3.1M) on 2018-02-08, disclosed to the SEC on 2018-02-08.
Open-market sale of $3.1M ALXN by CEO. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $116.31 | 13,245 | $1.5M | 50.0% |
| 2 | $116.31 | 13,245 | $1.5M | 50.0% |
| Total | $116.31 avg | 26,490 | $3.1M | 100% |
| Filing → |
| ALXN | BUY | 2017-06-19 | $1.2M | — | Filing → |
| BAX | SELL | 2014-07-11 | $1.9M | — | Filing → |
| BAX | SELL | 2013-01-29 | $710K | — | Filing → |